- Home
- SGMT vs LPTH Comparison
SGMT vs LPTH Comparison
Compare SGMT & LPTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGMT
- LPTH
- Stock Information
- Founded
- SGMT 2006
- LPTH 1985
- Country
- SGMT United States
- LPTH United States
- Employees
- SGMT N/A
- LPTH N/A
- Industry
- SGMT
- LPTH Semiconductors
- Sector
- SGMT
- LPTH Technology
- Exchange
- SGMT Nasdaq
- LPTH Nasdaq
- Market Cap
- SGMT 71.2M
- LPTH 81.1M
- IPO Year
- SGMT 2023
- LPTH 1996
- Fundamental
- Price
- SGMT $3.26
- LPTH $2.44
- Analyst Decision
- SGMT Strong Buy
- LPTH Strong Buy
- Analyst Count
- SGMT 6
- LPTH 3
- Target Price
- SGMT $25.67
- LPTH $4.67
- AVG Volume (30 Days)
- SGMT 553.5K
- LPTH 102.8K
- Earning Date
- SGMT 05-08-2025
- LPTH 05-15-2025
- Dividend Yield
- SGMT N/A
- LPTH N/A
- EPS Growth
- SGMT N/A
- LPTH N/A
- EPS
- SGMT N/A
- LPTH N/A
- Revenue
- SGMT N/A
- LPTH $32,158,517.00
- Revenue This Year
- SGMT N/A
- LPTH $16.90
- Revenue Next Year
- SGMT N/A
- LPTH $52.77
- P/E Ratio
- SGMT N/A
- LPTH N/A
- Revenue Growth
- SGMT N/A
- LPTH N/A
- 52 Week Low
- SGMT $1.73
- LPTH $1.04
- 52 Week High
- SGMT $7.38
- LPTH $4.42
- Technical
- Relative Strength Index (RSI)
- SGMT 52.50
- LPTH 60.73
- Support Level
- SGMT $3.19
- LPTH $2.27
- Resistance Level
- SGMT $3.45
- LPTH $2.55
- Average True Range (ATR)
- SGMT 0.31
- LPTH 0.16
- MACD
- SGMT 0.05
- LPTH 0.03
- Stochastic Oscillator
- SGMT 51.27
- LPTH 83.08
About SGMT Sagimet Biosciences Inc. Series A
Sagimet Biosciences Inc is a clinical-stage biopharmaceutical company dedicated to developing a portfolio of in-house discovered, selective fatty acid synthase (FASN) inhibitors aimed at treating diseases that arise from dysfunctional lipid metabolism pathways. The company's drug candidate, denifanstat, is an oral, once-daily pill that serves as a selective FASN inhibitor under development for treating nonalcoholic steatohepatitis (NASH). The company functions as a single business segment, focusing on the development and commercialization of therapeutics for MASH and other diseases where FASN plays a pathogenic role.
About LPTH LightPath Technologies Inc.
LightPath Technologies Inc is a manufacturer, distributor, and integrator of proprietary optical components and assemblies. It is also engaged in the research and development for optical solutions for the traditional optics markets and communications markets. The company's business based on the following product groups: precision molded optics, specialty products, and infrared products. It currently serves the following major markets, distribution and catalog, laser, industrial, instrumentation, telecommunications, and defense.